Wealth Advisory Solutions, LLC Gilead Sciences, Inc. Transaction History

Wealth Advisory Solutions, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	BUY	$57.72 - $65.01 $187,705 - $211,412	3,252 New	3,252 $201,000
Q3 2020 Dec 29, 2020	SELL	$62.1 - $78.08 $176,798 - $222,293	-2,847 Closed	0 $0
Q2 2020 Dec 23, 2020	SELL	$72.34 - $84.0 $61,995 - $71,988	-857 Reduced 23.14%	2,847 $219,000
Q1 2020 Dec 18, 2020	BUY	$62.63 - $80.22 $18,225 - $23,344	291 Added 8.53%	3,704 $276,000
Q4 2019 Jan 27, 2021	BUY	$61.62 - $67.78 $210,309 - $231,333	3,413 New	3,413 $221,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Wealth Advisory Solutions, LLC, based on Form 13F filings with the SEC.

Stay updated on Wealth Advisory Solutions, LLC with notifications on news.